Audien Atom X vs Lexie B3

The Audien Atom X is a budget OTC hearing aid priced at $389 that earns a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear style device ranks #54 of 65 OTC hearing aids tested, placing it in the bottom portion of its category. In our testing, the Atom X shows a mixed performance profile with notable strengths and weaknesses. Music streaming quality is a standout, scoring 3.3/5—a solid result that sits 1.38 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling issues. However, the core speech intelligibility metrics are where this device falls short: speech in quiet scores just 1.5/5 (1.25 points below the OTC average), and speech in noise scores 1.0/5 (0.48 points below average). Own-voice comfort is mixed at 2.3/5, slightly below the category norm. At this price point, several alternatives offer stronger overall performance. Devices like the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5) score meaningfully higher in the same price range. For those prioritizing value, the JLab Hear OTC delivers a similar SoundScore of 3.54/5 at a lower price. The Atom X may appeal to users who prioritize music streaming quality and want simple rechargeable convenience, but those seeking improved speech clarity—especially in challenging listening environments—should consider higher-performing alternatives in this competitive OTC category.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.